Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REHYTRI: Reverse Hybrid vs Standard Triple Therapy for H. pylori
NCT02359435Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Oct 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of metronidazole in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated. Started Oct 2012; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02359435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359435.